BioInnovation Africa | ABSCH-CBI-SCBD-248271 | Capacity-building Initiative | Access and Benefit-Sharing Clearing-House

PDF   |   Print   |  

Capacity-building Initiative (CBI)

  published:21 Oct 2019

BioInnovation Africa
  • Africa - All countries
  • Cameroon
  • Madagascar
  • Namibia
  • South Africa
January 1, 2019
June 30, 2022
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH (GIZ)
1-5 Dag-Hammarskjöld-Weg
65760, Germany
Phone: +49 6196 79-0,
Fax: +49 6196 79-11 15,
Websites: Google Maps, website,
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH (GIZ)
1-5 Dag-Hammarskjöld-Weg
65760, Germany
Phone: +49 6196 79-0,
Fax: +49 6196 79-11 15,
Websites: Google Maps, website,
- Person: Friedrich zur Heide
Friedrich zur Heide
Project Coordinator, GloBe
Friedrich-Ebert-Allee 40 Bonn,
Phone: +49-228-4460-1991,
GIZ Website - BioInnovation Africa (
GIZ_Factsheet_BioInnovation Africa_en.pdf (/api/v2013/documents/A80128D7-B520-151F-98CB-537975FBF157/attachments/GIZ_Factsheet_BioInnovation%20Africa_en.pdf)
Detailed information
Objective The European-African partnerships for biodiversity-based innovations and products have been strengthened with equitable benefit-sharing for conservation and sustainable use of biodiversity. Moreover, the private sector has entered into sustainable and mutually beneficial business partnerships based on high ethical, social and environmental standards. Approach The BioInnovation Africa project endeavours to support four African countries in the implementation of their national ABS systems by supporting the conclusion of benefit-sharing agreements between African providers of raw biological materials and ingredients, and users from Europe. These users are predominantly enterprises from the food, cosmetics and pharmaceutical sectors as well as research institutions. Measures involve blended learning trainings, advice on contracts and the development of IT-based online systems for ABS applications, permissions and tracking. The agreed monetary and non-monetary benefits stipulated by the benefit-sharing agreements contribute to gender-sensitive measures for the sustainable use and protection of ecosystems in the partner countries. In this context, vulnerability assessments, cost-benefit analyses and knowledge sharing between partner countries are conducted. These new collaboration agreements will be publicly promoted through trade fairs, round tables, meetings and business associations. Based on these agreements, BioInnovation Africa ensures that biodiversity-based raw materials and ingredients from the four African partner countries are used for developing innovations and products under equitable benefit-sharing mechanisms. In order to encourage long-term business relations between providers and users, the project facilitates various formats, such as matchmaking and exchange platforms. Likewise, BioInnovation promotes joint ventures and technology transfer to increase local value addition and job creation.
  • Civil society organizations
  • Government
  • National/Federal
  • Sub-national
  • Indigenous people and local communities
  • Private Sector
  • Online learning (e-learning modules, webinars, etc.)
  • Provision of capacity development tools, resources and knowledge products
  • Institutional capacity development
  • Matchmaking and fundraising support
  • Provision of legal/technical support
  • Trainings
  • Workshops
Information on funding
  • Government budget
German Federal Ministry for Economic Cooperation and Development (BMZ)
Dahlmannstraße 4
53045, Germany
Phone: +49 228 99 535-0,
Websites: Google Maps, website,
Capacity-building outcomes
Access and Benefit Sharing Clearing-House (ABS-CH)
  • Key area 4: Capacity needs and priorities of indigenous and local communities and relevant stakeholders, including the business sector and the research community
  • 1.2 Raising awareness of the importance of GR and TK, and related ABS issues
  • 3.2 Developing model sectoral and cross-sectoral contractual clauses
  • 3.3 Developing and implementing pilot ABS agreements
  • 3.4 Promoting better understanding of business models in relation to the utilization of genetic resources
  • 4.2 Developing minimum requirements, as appropriate for MAT to secure the fair and equitable sharing of benefits arising from the utilization of TK
  • 4.4 Developing model contractual clauses for benefit-sharing arising from the utilization of TK
  • 4.5 Enhancing the capacity of ILCs, in particular women within those communities, in relation to access to genetic resources and/or TK
  • 4.7 Increasing understanding of the obligations of Parties
Additional Information